Granules India Limited | GRANULES | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
14,35316,91822,79225,98632,375
Cost of revenue
Cost of revenue
-6,796-8,963-12,556-12,809-13,913
Gross Profit
Gross Profit
7,556
7,955
10,236
13,177
18,463
Sales, general & ad...
Sales, general and administrative
-4,321-5,099-6,396-7,924-9,910
Depreciation
Depreciation and amortization
-715-762-1,055-1,370-1,515
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
-247-72000
Operating income
Operating income EBIT
2,273
2,022
2,786
3,884
7,038
 
      
Profit before tax
Profit before tax
2,0501,8002,7684,2567,044
Net Income
Net income
1,645
1,326
2,364
3,354
5,495
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
7.52
5.49
9.30
13.19
22.05